Skip to content

ANIP ANI PHARMACEUTICALS INC

Follow

COM (common), issuer CIK 1023024

203 managers (207 13F filers) reported a position in ANIP shares at 2024-12-31, 19,306,843 shares in all. 25 filers opened a position and 31 filers sold out during the quarter.

Managers
203
13F filers
207
New
25
Added
69
Reduced
60
Sold out
31
Shares held by filers
19,306,843

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Cook Meredithofficer (SR. VP, GENERAL COUNSEL & SEC.)2026-10-13-500 S$73.59Form 4

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Kiely Wealth Advisory Group, Inc.1$60<0.01%013F-HRTimeline
HUNTINGTON NATIONAL BANKin group HUNTINGTON NATIONAL BANK1$55<0.01%013F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • Cook Meredith sold 500 ANIP shares on 2026-10-13, Form 4 filed 2026-10-13. 0001938861-26-000028

    Accepted , ingested